AAV9-Follistatin gene therapy

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AAV9-Follistatin gene therapy
Treatment and conditionWhere it standsTrials
AAV9-Follistatin gene therapy for sarcopeniaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1